Home › Entities › clinical_trial › Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC

Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC

clinical trial
MedicalStudy clinical_trial Q64675525
Press Enter · cited answer in seconds

Summary

Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC is a clinical trial[1].

Key Facts

  • Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC is located in Hong Kong[2].
  • Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC is in the country of Argentina[3].
  • Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC is in the country of Australia[4].
  • Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC is in the country of Canada[5].
  • Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC is in the country of France[6].
  • Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC is in the country of Italy[7].
  • Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC is in the country of Japan[8].
  • Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC's instance of is recorded as clinical trial[9].
  • Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC's start time is recorded as +2009-07-20T00:00:00Z[10].
  • Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC's end time is recorded as +2012-09-28T00:00:00Z[11].
  • Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC's sponsor is recorded as Bristol-Myers Squibb[12].
  • Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC's main subject is recorded as carcinoma[13].
  • Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC's number of participants is recorded as {'unit': '1', 'amount': '+734'}[14].
  • Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC's title is recorded as A Randomized, Double-blind, Multicenter Phase III Study of Brivanib Versus Placebo as Adjuvant Therapy to Trans-Arterial Chemo-Embolization (TACE) in Patients With Unresectable Hepatocellular Carcinoma (The BRISK TA Study)[15].
  • Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC's short name is recorded as BRISK TA[16].
  • Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[17].
  • Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC's ClinicalTrials.gov ID is recorded as NCT00908752[18].
  • Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC's clinical trial phase is recorded as phase III clinical trial[19].
  • Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC's research site is recorded as Montefiore Medical Center[20].
  • Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC's research site is recorded as Rhode Island Hospital[21].
  • Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC's research site is recorded as University of Texas at Houston Police Department[22].
  • Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC's research site is recorded as University of Virginia[23].
  • Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC's research site is recorded as University of Washington[24].
  • Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC's study type is recorded as interventional study[25].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [3] ↑ . wikidata.org.
  2. [4] ↑ . wikidata.org.
  3. [5] ↑ . wikidata.org.
  4. [6] ↑ . wikidata.org.
  5. [7] ↑ . wikidata.org.
  6. [8] ↑ . wikidata.org.
  7. [9] ↑ . wikidata.org.
  8. [2] ↑ . wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . wikidata.org.
  11. [12] ↑ . wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . wikidata.org.
  14. [15] ↑ . wikidata.org.
  15. [16] ↑ . wikidata.org.
  16. [17] ↑ . wikidata.org.
  17. [18] ↑ . wikidata.org.
  18. [19] ↑ . wikidata.org.
  19. [20] ↑ . wikidata.org.
  20. [21] ↑ . wikidata.org.
  21. [22] ↑ . wikidata.org.
  22. [23] ↑ . wikidata.org.
  23. [24] ↑ . wikidata.org.
  24. [25] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC. Retrieved May 3, 2026, from https://4ort.xyz/entity/phase-iii-trans-arterial-chemo-embolization-tace-adjuvant-hcc
MLA “Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/phase-iii-trans-arterial-chemo-embolization-tace-adjuvant-hcc.
BibTeX @misc{4ortxyz_phase-iii-trans-arterial-chemo-embolization-tace-adjuvant-hcc_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC}}, year = {2026}, url = {https://4ort.xyz/entity/phase-iii-trans-arterial-chemo-embolization-tace-adjuvant-hcc}, note = {Accessed: 2026-05-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC — https://4ort.xyz/entity/phase-iii-trans-arterial-chemo-embolization-tace-adjuvant-hcc (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/phase-iii-trans-arterial-chemo-embolization-tace-adjuvant-hcc · Last refreshed: